Unknown

Dataset Information

0

CRISPR-Cas12-based detection of SARS-CoV-2.

ABSTRACT: An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 infection, rapidly spread to produce a global pandemic. We report development of a rapid (<40 min), easy-to-implement and accurate CRISPR-Cas12-based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated our method using contrived reference samples and clinical samples from patients in the United States, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections. Our CRISPR-based DETECTR assay provides a visual and faster alternative to the US Centers for Disease Control and Prevention SARS-CoV-2 real-time RT-PCR assay, with 95% positive predictive agreement and 100% negative predictive agreement.

SUBMITTER: Broughton JP 

PROVIDER: S-EPMC9107629 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 infection, rapidly spread to produce a global pandemic. We report development of a rapid (<40 min), easy-to-implement and accurate CRISPR-Cas12-based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated our method using contrived reference samples and clinical samples from patients in the  ...[more]

Similar Datasets

Unknown iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
| S-EPMC7434412 | biostudies-literature
Unknown Detection of Infectious Viruses Using CRISPR-Cas12-Based Assay.
| S-EPMC8468381 | biostudies-literature
Unknown SARS-CoV-2 Direct Detection Without RNA Isolation With Loop-Mediated Isothermal Amplification (LAMP) and CRISPR-Cas12.
| S-EPMC7928313 | biostudies-literature
Unknown Evaluation of a Lyophilized CRISPR-Cas12 Assay for a Sensitive, Specific, and Rapid Detection of SARS-CoV-2.
| S-EPMC7998296 | biostudies-literature
Unknown Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.
| S-EPMC8257267 | biostudies-literature
Unknown CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV.
| S-EPMC8125043 | biostudies-literature
Unknown CRISPR-based assays for rapid detection of SARS-CoV-2.
| S-EPMC7546951 | biostudies-literature
Unknown SARS-CoV-2 detection with CRISPR diagnostics.
| S-EPMC7235268 | biostudies-literature
Unknown CRISPR-Cas12a-Based Detection of SARS-CoV-2 Harboring the E484K Mutation.
| S-EPMC8610009 | biostudies-literature
Unknown COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme.
| S-EPMC9297821 | biostudies-literature